Ottobock rises after Q2 earnings beat, FY outlook hike

Ottobock SE & Co KgaA

13/08/2026 08:24

** Shares in Ottobock OBCK.DE rise 3.6% after the German human bionics firm reported a Q2 EBITDA beat and raised the lower end of its 2026 revenue outlook
** Ottobock now expects 2026 organic core revenue growth of 6%-8%, versus 5%-8% previously, and an underlying core EBITDA margin above 27.0%, versus above 26.5% before
** Jefferies says Q2 underlying core EBITDA was about 6% above Vara consensus, helped by favourable product mix, procurement efficiencies, operating leverage and cost discipline
** The broker notes Q2 core sales were broadly in line with consensus, while B2B organic growth accelerated to 11.7% from 5.5% in Q1 
** Including today's rise, the stock is down 6.51% YTD

 (Reporting by Kira Britten)
 ((Kira.Britten@thomsonreuters.com))